Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Human Genetics01:28

Human Genetics

1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Nature microbiology·2026
Same author

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Communications medicine·2026
Same author

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Communications medicine·2026
Same author

Host Genetic Architecture between Epstein-Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways.

medRxiv : the preprint server for health sciences·2025
Same author

Unravelling the complex inflammatory landscape of COVID-19 infection: a pathway to biomarkers identification in infection-associated delirium in the ICU.

Intensive care medicine experimental·2025
Same author

Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.

Journal of immunology (Baltimore, Md. : 1950)·2025

Related Experiment Video

Updated: Mar 22, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K

Multiple sclerosis: genetics, biomarkers, treatments.

Pierre-Paul Axisa1, David A Hafler

  • 1aDepartments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA bCentre National de la Recherche Scientifique, U5282 cCentre de Physiopathologie Toulouse-Purpan, Université Toulouse 3 dINSERM, U1043, Toulouse, France eBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Current Opinion in Neurology
|April 9, 2016
PubMed
Summary

New genetic analysis and biomarkers are revolutionizing the understanding and treatment of multiple sclerosis (MS). These advances offer improved patient care and pave the way for novel therapeutic strategies in managing this complex neurological disease.

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K

Related Experiment Videos

Last Updated: Mar 22, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.6K

Area of Science:

  • Neuroimmunology
  • Genetics
  • Biomarker Discovery

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Understanding MS immunopathology is crucial for developing effective treatments.

Purpose of the Study:

  • To review new paradigms in understanding MS immunopathology.
  • To highlight advancements in genetic analysis, biomarker development, and treatment options.

Main Methods:

  • Genome-wide association studies (GWAS) for etiological insights.
  • Identification and validation of candidate biomarkers.
  • Analysis of emerging immunomodulatory treatments.

Main Results:

  • GWAS have identified numerous genes linked to immune regulation in MS.
  • New biomarkers are available for monitoring disease progression and treatment response.
  • A growing arsenal of immunomodulatory therapies shows promise for improved clinical outcomes.

Conclusions:

  • Recent breakthroughs enhance the understanding of MS physiopathology, patient follow-up, and treatment.
  • Future challenges include modeling MS progression to develop targeted therapeutics and elucidate neurodegeneration mechanisms.